Alphatec Holdings (ATEC)

• Market cap: $1.54B
• 1 day: 9.13%
• 5 days: 14.77%
• 1 month: 13.10%
• 3 months: 104.51%
• 6 months: -4.73%
• Year to date: 20.09%
• 1 year: -27.71%
• 5 years: 47.83%
• 10 years: -35.24%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Employees: 839

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

48% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 58

1% less funds holding

Funds holding: 216 [Q2] → 214 (-2) [Q3]

2% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 44

7.96% less ownership

Funds ownership: 69.88% [Q2] → 61.92% (-7.96%) [Q3]

53% less capital invested

Capital invested by funds: $1.02B [Q2] → $483M (-$538M) [Q3]

53% less call options, than puts

Call options by funds: $2.64M | Put options by funds: $5.61M

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $16 47% upside
• Avg. target: $18.67 72% upside
• High target: $20 84% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Needham David Saxon 22% 1-year accuracy 14 / 63 met price target	47% upside $16	Buy Maintained	13 Jan 2025
Barclays Matt Miksic 65% 1-year accuracy 24 / 37 met price target	84% upside $20	Overweight Maintained	19 Nov 2024
HC Wainwright & Co. Sean Lee 67% 1-year accuracy 14 / 21 met price target	84% upside $20	Buy Reiterated	31 Oct 2024